Evommune, Inc. · NYSE:EVMN
Evommune, Inc. shareholders
As of Jun 30, 2026, 101 institutions reported holding Evommune, Inc., 95.4% of its shares. Largest: EQT Fund Management S.a r.l., Ra Capital Management, L.P. and T. Rowe Price. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Evommune, Inc. | Change | Filed |
|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.29M | 14.6% | +359K | Aug 13, 2026 |
| Ra Capital Management, L.P. | 3.49M | 9.6% | no change | Aug 14, 2026 |
| T. Rowe Price | 1.94M | 5.3% | +822K | Aug 14, 2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.93M | 5.3% | no change | Aug 13, 2026 |
| JPMorgan | 1.55M | 4.3% | +93,712 | Aug 12, 2026 |
| Rtw Investments, LP | 1.5M | 4.1% | no change | Aug 14, 2026 |
| Nan Fung Group Holdings Ltd | 1.44M | 4.0% | no change | Aug 13, 2026 |
| Point72 Asset Management, L.P. | 1.44M | 4.0% | +1.4M | Aug 14, 2026 |
| Andera Partners | 1.39M | 3.8% | −505K | Jul 22, 2026 |
| Eventide Asset Management, LLC | 1.21M | 3.3% | no change | Aug 14, 2026 |